D34 - Molecular Targeting and Drug Design in Neurological and Bacterial Diseases

The main objective of the Action is to build on existing knowledge at the chemistry/biology interface, in order to develop new targetoriented molecules and classes of molecules with therapeutic applications in the area of bacterial and neurological diseases. Molecular targeting covers drug design, both on the basis of mechanistic studies and of structural studies of the molecules.